| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_994d1034e8cc636d2029b05fc7aa2ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b47d11aff6beca7e84541080dc0e9f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5eeafbd30a466c42250fbf49fa5cd920 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2001-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e83439e329e1539214ec16d6d1d196c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1615a3b1f84ce9d079d4aca2576d2519 |
| publicationDate |
2001-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0192295-A2 |
| titleOfInvention |
Ligands for cd21 and compositions thereof for modulating immune responses |
| abstract |
Ligands for the CD21 molecule corresponding to the CD21 contacting amino acid residies 36-39 and 160-167 of the C3d molecule are provided. These ligands have the ability to bind CD21 and stimulate the CD21/CD19 complex and may be polypeptides, peptides or mimetics. The ligands coupled to antigens modulate the immune response of hosts immunized therewith. Site-specific mutated analogs of C3d are provided that have enhanced binding to CD21. |
| priorityDate |
2000-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |